[HTML][HTML] Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors

JC Heemelaar, ADG Krol, M Louwerens… - IJC Heart & …, 2021 - Elsevier
Background Thoracic irradiation is one of the cornerstones of Hodgkin lymphoma (HL)
treatment, which contributes to high rates of long-term survivorship, but begets a life-long …

Right Ventricle and Radiotherapy: More Questions than Answers

M Tadic, J Kersten, D Buckert, W Rottbauer, C Cuspidi - Diagnostics, 2023 - mdpi.com
The injury of the left ventricle (LV) during anticancer therapy has long been recognized, and
guidelines recommend a specific set of parameters for determination of LV impairment. The …

[HTML][HTML] Two-dimensional speckle tracking echocardiography in evaluating radiation-induced heart damage

T Li, H Zhuang, Y Wang, J Li, D Zhu, M Cui - Asia-Pacific Journal of …, 2022 - Elsevier
Objective Radiation-induced heart damage (RIHD) in malignant tumor patients with thoracic
radiotherapy has been well documented. However, there is no study on the cardiac toxicity …

乳腺癌保乳术后大分割放疗亚临床心脏损伤的前瞻性研究.

陈偲晔, 王淑莲, 唐玉, 张江鹄… - Chinese Journal of …, 2020 - search.ebscohost.com
目的观察左侧乳腺癌保乳术后放疗患者早期心脏损伤的发生情况, 探讨大分割放疗与心脏损伤的
剂量效应关系. 方法前瞻性入组103 例左侧乳腺癌保乳术后行全乳±淋巴引流区放疗患者 …

Impaired global longitudinal strain is associated with cardiovascular events in Hodgkin lymphoma survivors

EAS Polomski, JC Heemelaar, ADG Krol, M Louwerens… - Cancers, 2022 - mdpi.com
Simple Summary Radiotherapeutic treatment in classic Hodgkin lymphoma (CHL) survivors
contributes to long-term survival but is associated with lifetime increased risk of …

The role of advanced cardiovascular imaging modalities in cardio-oncology: from early detection to unravelling mechanisms of cardiotoxicity

I Leo, M Vidula, G Bisaccia, MC Procopio… - Journal of Clinical …, 2023 - mdpi.com
Advances in cancer therapies have led to a global improvement in patient survival rates.
Nevertheless, the price to pay is a concomitant increase in cardiovascular (CV) morbidity …

Cancer therapy-related cardiac dysfunction after radiation therapy for breast cancer: results from the BACCARAT cohort study

MK Honaryar, M Locquet, RS Allodji, G Jimenez… - 2024 - researchsquare.com
Background: Radiation therapy (RT) for breast cancer (BC) can result in subtle cardiac
dysfunction that can occur early after treatment. In 2022, the European Society of Cardiology …

[PDF][PDF] Role of cardiac biomarkers in cancer patients. Cancers 2021; 13: 5426

GC Semeraro, CM Cipolla, DM Cardinale - 2021 - academia.edu
In patients with cancer—and especially some specific subtypes—the heart can be
pathologically affected due to the direct action of the tumor or its secretion products or due to …

[HTML][HTML] Redefining Heart Failure in Breast Cancer

AS Volgman, C Brezden-Masley, T Okwuosa - Cardio Oncology, 2022 - jacc.org
The Women's Health Initiative study began in 1992, investigating various health aspects
among women. In 2002, the landmark study revealed that estrogen plus progestin given to …

[PDF][PDF] ÍNDICE PREDICTIVO DE CARDIOTOXICIDAD PRECOZ POR QUIMIOTERAPIA EN PACIENTES CON CÁNCER DE MAMA

JAP DOMÍNGUEZ - 2022 - tesis.sld.cu
Método: estudio analítico de cohorte única en 629 pacientes con cáncer de mama en
tratamiento con quimioterapia seguidas en consulta de Cardiooncología del Hospital …